LXRX Earnings

LXRX reported its FY2025Q3 earnings on 2025-11-06, showcasing a revenue of 14.00M against an estimate of 5.00M, resulting in a 205.04% surprise. The EPS was -0.04, surpassing the expected -0.07 by 42.86% . The stock experienced a 3.62% price change on the earnings day and a 13.04% change over the next five days, reflecting market reactions to the results.

Following LXRX's FY2025Q3 earnings announcement on 2025-11-06, the stock price moved by 3.62% on the day of the release. Over the subsequent five days, it saw a 13.04% change. Historically, LXRX's stock price tends to shift by an average of +10.64% in the 10 days leading up to earnings and -5.16% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate LXRX’s annual revenue to reach 3.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 12.62% and EPS estimates Revise Downward by -44.98% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between LXRX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 12.62%, while EPS estimates moved Revise Downward by -44.98% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, LXRX's stock price typically moves by +10.64% in the 10 days before its earnings and -5.16% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 3.00M.

The earnings call summary reveals a positive sentiment due to reduced net loss, strategic repositioning, and promising product developments. Key partnerships and ongoing trials indicate growth potential. The Q&A section supports this with insights into strategic planning and regulatory progress. Despite some management vagueness, the overall tone suggests optimism. The financial guidance, reduced expenses, and strong pipeline developments contribute to a positive outlook, likely leading to a stock price increase in the short term.